| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/18/2011 | CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 05/18/2011 | CN102066328A Iminopyridine derivative and use thereof |
| 05/18/2011 | CN102066327A Iminopyridine derivatives and use thereof |
| 05/18/2011 | CN102066323A Novel estrogen receptor ligands |
| 05/18/2011 | CN102065841A Treatment of bladder dysfunction using liposomal botulinum toxin |
| 05/18/2011 | CN102060888A Novel compounds |
| 05/18/2011 | CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/18/2011 | CN102060809A Rhein derivatives and preparation and application thereof |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102060732A 5-amino-4-hydroxy-N-aryl azelamide derivatives as well as preparation methods and medical applications thereof |
| 05/18/2011 | CN102058892A Material mixture based on a mixture of ether oils and use of same |
| 05/18/2011 | CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
| 05/18/2011 | CN102058885A Combination therapy of lower urinary tract disorders with Alpha2Delta ligands and NSAIDs |
| 05/18/2011 | CN102058806A Preparation method and application of compound polygonum multiflorum preparation |
| 05/18/2011 | CN102058715A Chinese medicine preparation for treating chronic prostatitis and preparation method thereof |
| 05/18/2011 | CN102058654A Astragalus membranaceus dispersible tablet and preparation method thereof |
| 05/18/2011 | CN102058580A New application of 15-oxospiramilactone to inhibition of Wnt signal path |
| 05/18/2011 | CN102058555A Doxazosin controlled release tablet |
| 05/18/2011 | CN102058549A Finasteride-containing orally disintegrating tablets and preparation method thereof |
| 05/18/2011 | CN102058547A Freeze-dried preparation |
| 05/18/2011 | CN102058540A Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof |
| 05/18/2011 | CN101695555B Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof |
| 05/18/2011 | CN101485641B Finasteride and doxazosin compound controlled release capsule and use thereof |
| 05/18/2011 | CN101348760B Health preserving wine |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | CA2592733C Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011055869A1 Compositions for treatment and prevention of diabetic complications using osteomeles schwerinae |
| 05/12/2011 | WO2011055838A1 Compound for inhibiting biosynthesis of testosterone |
| 05/12/2011 | WO2010138393A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | WO2010138389A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112168 Novel sirna structures |
| 05/12/2011 | US20110112160 Tablet comprising eprosartan mesylate |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110899 Combined Chemical and Genetic Approaches for Generation of Induced Pluripotent Stem Cells |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319826A1 Succinate salt of O-desmethyl-venlafaxin |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319522A1 An aqueous solution for treating nefrolithiasis comprising active ingredients from citrus fruits of the genus Citrus (Citrus limonum, Citrus aurantifolia) in the family Rutaceae and of the leaves of seagrape (Coccoloba uvifera). |
| 05/11/2011 | EP2318415A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 05/11/2011 | EP2318038A1 A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 05/11/2011 | EP2317991A1 Use of opioid antagonists for treating urinary retention |
| 05/11/2011 | EP2317987A1 Eprosartan compositions |
| 05/11/2011 | EP1061803B1 Compositions of eprosartan |
| 05/11/2011 | CN201823042U Smokeless medicinal bean blowing moxibustion instrument |
| 05/11/2011 | CN1917883B Use of treprostinil in preparing medicine to improve kidney functions |
| 05/11/2011 | CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 05/11/2011 | CN102056907A Heterocyclic derivative and use thereof |
| 05/11/2011 | CN102056621A A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 05/11/2011 | CN102048997A Medicament for treating infantile enuresis, and preparation method and quality detection method thereof |
| 05/11/2011 | CN102048990A Quality control method for Chinese medicinal preparation Qinggong Shoutao pills |
| 05/11/2011 | CN102048984A Blood tonifying tablets and preparation method thereof |
| 05/11/2011 | CN102048975A Traditional Chinese medicine composition for treating nephritic hematuria |
| 05/11/2011 | CN102048956A Medicinal liquor |
| 05/11/2011 | CN102048952A Chinese medicinal preparation for treating benign postatic hyperplasia |
| 05/11/2011 | CN102048950A Nourishing and strengthening health wine and preparation method thereof |
| 05/11/2011 | CN102048948A Method for preparing medlar-poria kidney strengthening ointment |
| 05/11/2011 | CN102048898A Formula of medicament for strengthening spleen and invigorating kidney |
| 05/11/2011 | CN102048871A Formula of traditional Chinese medicine for treating renal calculus |
| 05/11/2011 | CN102048859A Anti-infective Chinese medical composition and preparation method thereof |
| 05/11/2011 | CN102048840A Traditional Chinese medicine composition sore external application tincture and preparation method thereof |
| 05/11/2011 | CN102048795A Method for simultaneously measuring content of multiple active ingredients in common threewingnut root medicinal materials |
| 05/11/2011 | CN102048777A Panax root extract detection method |
| 05/11/2011 | CN102048770A Artificially-cultured cordceps militaris sporocarp extract and preparation process thereof |
| 05/11/2011 | CN102048756A Use of human fat-derived mesenchymal stem cells in treatment of diseases in kidney and ocular fundus |
| 05/11/2011 | CN102048747A Tulathromycin composition used for treating or preventing pet bacterial diseases and preparation method thereof |
| 05/11/2011 | CN102048746A Application of dioscin in preventing and treating diabetic complications |
| 05/11/2011 | CN102048706A Darifenacin hydrobromide sustained-release tablet and preparation method |
| 05/11/2011 | CN102048699A Preparation method for sustained release microsphere of injection triptorelin acetate |
| 05/11/2011 | CN102048685A Pefloxacin mesylate injection and preparation method and application thereof |
| 05/11/2011 | CN102048679A Transdermal preparation containing silodosin, preparation method and medicinal application thereof |
| 05/11/2011 | CN102048678A Transdermal absorption preparation of oxybutynin as well as preparation method and medication application thereof |
| 05/11/2011 | CN102048675A Fragrant grass vagina cleaning liquid and preparation process thereof |
| 05/11/2011 | CN102047888A Herbicidal composition |
| 05/11/2011 | CN101637576B Traditional Chinese medicine for treating nephritis |
| 05/11/2011 | CN101376008B Pure medicinal formulation for tonifying kidney and replenishing essence and preparation method thereof |
| 05/11/2011 | CN101361943B Production method of capsule for conditioning and treating kidney deficiency |
| 05/11/2011 | CN101274060B Loins-strengthening and kidney-invigorating paste |